InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by DOUGHERTY MICHAEL R, Director. Director active across 2 companies, notably Idera Pharmaceuticals, INC.. In total, 12 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €166k. Activity tracked since 1 June 2021. The latest transaction was filed on 11 January 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
33,523 shares@ US$0.444.3% of flowCommon StockSEC:0001415889-23-000919:0
58,516 shares@ US$0.37497.0% of flowCommon StockSEC:0001415889-22-010367:0
50,086 shares@ US$0.4386.6% of flowCommon StockSEC:0001415889-22-007483:0
41,155 shares@ US$0.5357.6% of flowCommon StockSEC:0001415889-22-003846:0
2,750 shares0Common StockSEC:0001104659-22-012782:0
2,750 shares0Common StockSEC:0001104659-22-012782
37,062 shares@ US$0.5915.9% of flowCommon StockSEC:0001415889-22-000389
37,062 shares@ US$0.597.4% of flowCommon StockSEC:0001415889-22-000389:0
21,229 shares@ US$1.037.2% of flowCommon StockSEC:0001104659-21-122658:0
21,229 shares@ US$1.035.9% of flowCommon StockSEC:0001104659-21-122658
85,000 shares@ US$1.1931.7% of flowCommon StockSEC:0001415889-21-002782:0
Ideal exit: 26 Feb 2022 (T+270)
85,000 shares@ US$1.1926.0% of flowCommon StockSEC:0001415889-21-002782
Ideal exit: 26 Feb 2022 (T+270)
12 of 12 declarations
About DOUGHERTY MICHAEL R
Michael R. Dougherty is a Director at IDERA PHARMACEUTICALS, INC. and MARINUS PHARMACEUTICALS INC. In this role, he participates in the governance of the companies and strategic decision-making. Dougherty brings his expertise to support the missions of these pharmaceutical companies.
